The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Intranasal Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2029
Synopsis
The global Intranasal Vaccine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Vaccines administered nasally
This report is a detailed and comprehensive analysis for global Intranasal Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Intranasal Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Intranasal Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Intranasal Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Intranasal Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Intranasal Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Intranasal Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, AstraZeneca, Abbott, GlaxoSmithKline and Serum Institute of India, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Intranasal Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Flu Vaccine
COVID-19 Vaccines
Market segment by Application
Hospital
Clinic
Major players covered
Sanofi
AstraZeneca
Abbott
GlaxoSmithKline
Serum Institute of India
Bharat Biotech
Antares Pharma
INJEX Pharma GmbH
BioDiem
PharmaJet and Crossject
Beijing Wantai Biopharmaceutical Co., Ltd.
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Intranasal Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Intranasal Vaccine, with price, sales, revenue and global market share of Intranasal Vaccine from 2018 to 2023.
Chapter 3, the Intranasal Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Intranasal Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Intranasal Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Intranasal Vaccine.
Chapter 14 and 15, to describe Intranasal Vaccine sales channel, distributors, customers, research findings and conclusion.
The global Intranasal Vaccine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Vaccines administered nasally
This report is a detailed and comprehensive analysis for global Intranasal Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Intranasal Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Intranasal Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Intranasal Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Intranasal Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Intranasal Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Intranasal Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, AstraZeneca, Abbott, GlaxoSmithKline and Serum Institute of India, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Intranasal Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Flu Vaccine
COVID-19 Vaccines
Market segment by Application
Hospital
Clinic
Major players covered
Sanofi
AstraZeneca
Abbott
GlaxoSmithKline
Serum Institute of India
Bharat Biotech
Antares Pharma
INJEX Pharma GmbH
BioDiem
PharmaJet and Crossject
Beijing Wantai Biopharmaceutical Co., Ltd.
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Intranasal Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Intranasal Vaccine, with price, sales, revenue and global market share of Intranasal Vaccine from 2018 to 2023.
Chapter 3, the Intranasal Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Intranasal Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Intranasal Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Intranasal Vaccine.
Chapter 14 and 15, to describe Intranasal Vaccine sales channel, distributors, customers, research findings and conclusion.
Index1 Market Overview
1.1 Product Overview and Scope of Intranasal Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Intranasal Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Flu Vaccine
1.3.3 COVID-19 Vaccines
1.4 Market Analysis by Application
1.4.1 Overview: Global Intranasal Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.5 Global Intranasal Vaccine Market Size & Forecast
1.5.1 Global Intranasal Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Intranasal Vaccine Sales Quantity (2018-2029)
1.5.3 Global Intranasal Vaccine Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Intranasal Vaccine Product and Services
2.1.4 Sanofi Intranasal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Sanofi Recent Developments/Updates
2.2 AstraZeneca
2.2.1 AstraZeneca Details
2.2.2 AstraZeneca Major Business
2.2.3 AstraZeneca Intranasal Vaccine Product and Services
2.2.4 AstraZeneca Intranasal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 AstraZeneca Recent Developments/Updates
2.3 Abbott
2.3.1 Abbott Details
2.3.2 Abbott Major Business
2.3.3 Abbott Intranasal Vaccine Product and Services
2.3.4 Abbott Intranasal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Abbott Recent Developments/Updates
2.4 GlaxoSmithKline
2.4.1 GlaxoSmithKline Details
2.4.2 GlaxoSmithKline Major Business
2.4.3 GlaxoSmithKline Intranasal Vaccine Product and Services
2.4.4 GlaxoSmithKline Intranasal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 GlaxoSmithKline Recent Developments/Updates
2.5 Serum Institute of India
2.5.1 Serum Institute of India Details
2.5.2 Serum Institute of India Major Business
2.5.3 Serum Institute of India Intranasal Vaccine Product and Services
2.5.4 Serum Institute of India Intranasal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Serum Institute of India Recent Developments/Updates
2.6 Bharat Biotech
2.6.1 Bharat Biotech Details
2.6.2 Bharat Biotech Major Business
2.6.3 Bharat Biotech Intranasal Vaccine Product and Services
2.6.4 Bharat Biotech Intranasal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Bharat Biotech Recent Developments/Updates
2.7 Antares Pharma
2.7.1 Antares Pharma Details
2.7.2 Antares Pharma Major Business
2.7.3 Antares Pharma Intranasal Vaccine Product and Services
2.7.4 Antares Pharma Intranasal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Antares Pharma Recent Developments/Updates
2.8 INJEX Pharma GmbH
2.8.1 INJEX Pharma GmbH Details
2.8.2 INJEX Pharma GmbH Major Business
2.8.3 INJEX Pharma GmbH Intranasal Vaccine Product and Services
2.8.4 INJEX Pharma GmbH Intranasal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 INJEX Pharma GmbH Recent Developments/Updates
2.9 BioDiem
2.9.1 BioDiem Details
2.9.2 BioDiem Major Business
2.9.3 BioDiem Intranasal Vaccine Product and Services
2.9.4 BioDiem Intranasal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 BioDiem Recent Developments/Updates
2.10 PharmaJet and Crossject
2.10.1 PharmaJet and Crossject Details
2.10.2 PharmaJet and Crossject Major Business
2.10.3 PharmaJet and Crossject Intranasal Vaccine Product and Services
2.10.4 PharmaJet and Crossject Intranasal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 PharmaJet and Crossject Recent Developments/Updates
2.11 Beijing Wantai Biopharmaceutical Co., Ltd.
2.11.1 Beijing Wantai Biopharmaceutical Co., Ltd. Details
2.11.2 Beijing Wantai Biopharmaceutical Co., Ltd. Major Business
2.11.3 Beijing Wantai Biopharmaceutical Co., Ltd. Intranasal Vaccine Product and Services
2.11.4 Beijing Wantai Biopharmaceutical Co., Ltd. Intranasal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Beijing Wantai Biopharmaceutical Co., Ltd. Recent Developments/Updates
3 Competitive Environment: Intranasal Vaccine by Manufacturer
3.1 Global Intranasal Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Intranasal Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global Intranasal Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Intranasal Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Intranasal Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 Intranasal Vaccine Manufacturer Market Share in 2022
3.5 Intranasal Vaccine Market: Overall Company Footprint Analysis
3.5.1 Intranasal Vaccine Market: Region Footprint
3.5.2 Intranasal Vaccine Market: Company Product Type Footprint
3.5.3 Intranasal Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Intranasal Vaccine Market Size by Region
4.1.1 Global Intranasal Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global Intranasal Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global Intranasal Vaccine Average Price by Region (2018-2029)
4.2 North America Intranasal Vaccine Consumption Value (2018-2029)
4.3 Europe Intranasal Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific Intranasal Vaccine Consumption Value (2018-2029)
4.5 South America Intranasal Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa Intranasal Vaccine Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Intranasal Vaccine Sales Quantity by Type (2018-2029)
5.2 Global Intranasal Vaccine Consumption Value by Type (2018-2029)
5.3 Global Intranasal Vaccine Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Intranasal Vaccine Sales Quantity by Application (2018-2029)
6.2 Global Intranasal Vaccine Consumption Value by Application (2018-2029)
6.3 Global Intranasal Vaccine Average Price by Application (2018-2029)
7 North America
7.1 North America Intranasal Vaccine Sales Quantity by Type (2018-2029)
7.2 North America Intranasal Vaccine Sales Quantity by Application (2018-2029)
7.3 North America Intranasal Vaccine Market Size by Country
7.3.1 North America Intranasal Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America Intranasal Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Intranasal Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe Intranasal Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe Intranasal Vaccine Market Size by Country
8.3.1 Europe Intranasal Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe Intranasal Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Intranasal Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Intranasal Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Intranasal Vaccine Market Size by Region
9.3.1 Asia-Pacific Intranasal Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Intranasal Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Intranasal Vaccine Sales Quantity by Type (2018-2029)
10.2 South America Intranasal Vaccine Sales Quantity by Application (2018-2029)
10.3 South America Intranasal Vaccine Market Size by Country
10.3.1 South America Intranasal Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America Intranasal Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Intranasal Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Intranasal Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Intranasal Vaccine Market Size by Country
11.3.1 Middle East & Africa Intranasal Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Intranasal Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Intranasal Vaccine Market Drivers
12.2 Intranasal Vaccine Market Restraints
12.3 Intranasal Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Intranasal Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Intranasal Vaccine
13.3 Intranasal Vaccine Production Process
13.4 Intranasal Vaccine Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Intranasal Vaccine Typical Distributors
14.3 Intranasal Vaccine Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
